Agilent Technologies Inc

A
Passed

Company Overview

Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. It operates through the following segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers application-focused solutions that include instruments and software that identify, quantify, and analyze the physical and biological properties of substances and products, as well as the clinical and life sciences research areas to interrogate samples at the molecular and cellular level. The Diagnostics and Genomics segment consists of activity providing active pharmaceutical ingredients for oligo-based therapeutics, as well as solutions that include reagents, instruments, software and consumables. The Agilent CrossLab segment includes startup, operational, training and compliance support, software as a service, and asset management and consultative services. The company was founded in May 1999 and is headquartered in Santa Clara, CA.

Country
US
Market Cap
$37.55B
Last Fiscal Year
2024
Final Shariah Status
Passed
Compliance Analysis Overview

Shariah Compliance Benchmarks:

  • Business Compliance: Non-Shariah compliant revenue must be less than 5% of total revenue
  • Liabilities Compliance: Interest-bearing debt must be less than 33% of market capitalization
Business Compliance
0.29% passed
5% Threshold
0.3%
Liabilities Compliance
9.04% passed
33% Threshold
9.0%
Final Shariah Status
Passed

This stock meets all Shariah compliance criteria according to AAOIFI standards.

Stock Information
Name Agilent Technologies Inc
Ticker A
Main Business Laboratory Analytical Instruments
Type Securities
Industry Diagnostics & Research
Country US
Market Cap $37.55 B

Shariah Analysis Breakdown

Business compliance Breakdown
Revenue Segment Value ($M) Non-Compliant ($M) Reason
Life sciences and applied markets $4,007.0 $0.0 -
Diagnostics and genomics $1,389.0 $0.0 -
Agilent CrossLab $1,452.0 $0.0 -
Interest income $9.0 $9.0 -
Net gain on equity securities sold during the period $11.0 $11.0 -
Total $6,868.0 $20.0 0.29% (passed)
Liabilities Compliance Breakdown
Liability Item Value ($M) % of Market Cap
current debt and capital lease obligation $45,000,000.0 0.12%
long term debt and capital lease obligation $3,350,000,000.0 8.92%
Total Interest-Bearing Debt $3,395,000,000.0 9.04%
Market Capitalization $37,553,544,000.0 100.00%
Compliance Status Threshold: 33% passed